FORMA THERAPEUTICS
FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers. FORMA’s approach to accessing such high value drug targets, many of which pose significant challenges to conventional discovery approaches, is rooted in the concerted integration of its innovative drug discovery technologies and oncology expertise, enabling sc... reening, discovery and rational development of a generation of small molecule drug candidates with cellular mechanisms of action. FORMA is building a pipeline of therapeutics directed at Achilles heels in human cancers, such as key targets associated with cancer stem cells, tumor cell metabolism, programmed cell death or epigenetic disease mechanisms. FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub and Michael Foley, each of the Broad Institute of Harvard and MIT. FORMA leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of breakthrough oncology drugs.
FORMA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.formatherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
617-679-1970
Email Addresses:
[email protected]
Total Funding:
142.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Reven Pharmaceuticals
Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
vTv Therapeutics
vTv Therapeutics is a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs.
Viriom
Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.
Medicure
Medicure is a specialty pharmaceutical Company engaged in the research, clinical development and commercialization of human therapeutics.
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
L.E.A.F. Pharmaceuticals
L.E.A.F. Pharmaceuticals is a pharmaceutical company that specializes in the fields of biotechnology, healthcare, and innovation management.
Agentix
Agentix is a biopharmaceutical company that focuses on the development of a suite of health solutions for patients and consumers.
Atlantic Healthcare
A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.
Alexza Pharmaceuticals
Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Talphera
Talphera focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Aradigm
Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.
Addex Therapeutics
Addex Therapeutics is a biopharmaceutical company that discovers and develops allosteric modulators for human health.
Apexian Pharmaceuticals
Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.
Audion Therapeutics
It is a private biopharmaceutical company dedicated to the discovery, development and commercialization of drugs and delivery technologies
Avenue Therapeutics
Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.
AN2 Therapeutics
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Amunix
Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Atea Pharmaceuticals
Atea Pharmaceuticals focuses on the discovery and development of next-generation therapeutics for severe human viral infections.
ApoGen Biotechnologies
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.
Accera
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Ark Biosciences
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Aptorum Group
Aptorum Group is a pharmaceutical company dedicated to the development of therapeutic assets to treat diseases with unmet medical needs.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Everest Medicines
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Enanta Pharmaceuticals
Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
BioNumerik Pharmaceuticals
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.
Trevi Therapeutics
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
QuVa Pharma
QuVa Pharma is a quality-compliant manufacturer of compounded and ready-to-administer sterile injectable products.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
858 Therapeutics
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
IntelGenX
IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.
ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Genova
Genova is a biotechnology company focusing on the development and production of insulin.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Orexigen Therapeutics
Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
XyloCor Therapeutics
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
CytomX Therapeutics
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Cure Pharmaceutical
Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.
Cytimmune Sciences
CytImmune Sciences focuses on the discovery, development and commercialization of multifunctional, tumor-targeted therapies.
Cardiome Pharma
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization.
Apollomics
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies.
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series D - FORMA Therapeutics
RA Capital Management
RA Capital Management investment in Series D - FORMA Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series D - FORMA Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series D - FORMA Therapeutics
Wellington Management
Wellington Management investment in Series D - FORMA Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series D - FORMA Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - FORMA Therapeutics
Lilly Ventures
Lilly Ventures investment in Series C - FORMA Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series B - FORMA Therapeutics
EDBI
EDBI investment in Series B - FORMA Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Forma Therapeutics Announces Appointment of New Executive Team Members |
Official Site Inspections
http://www.formatherapeutics.com Semrush global rank: 867.42 K Semrush visits lastest month: 43.35 K
- Host name: therefundcompany.com
- IP address: 192.254.187.248
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "FORMA Therapeutics"
Forma Therapeutics - LinkedIn
Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients ...See details»
Clinical-Stage Biopharmaceutical Company - Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.See details»
FORMA Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 617-679-1970 FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock …See details»
News Details - Novo Nordisk
Novo Nordisk announces the completion of the Forma Therapeutics acquisition. Bagsværd, Denmark, 14 October 2022 – Novo Nordisk today announced that the acquisition of Forma …See details»
Our Story - Forma Therapeutics
We got our start as a research firm, cutting our teeth in the industry by discovering new molecules. Our break-through work became a building block for new medicines. Soon …See details»
FORMA Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.formatherapeutics.com. Public Company | Subsidiary Company | 2007 | Massachusetts, United States | 100-250 | NASDAQ: FMTX | www.formatherapeutics.com. Last update 01 Nov …See details»
Novo Nordisk to acquire Forma Therapeutics and …
Sep 1, 2022 Copies of the documents filed with the SEC by Forma will be available free of charge on Forma’s website at https://ir.formatherapeutics.com or by contacting Forma’s Investor Relations ...See details»
Forma Therapeutics Announces Appointment of New ... - Business …
Jun 30, 2022 Since 2014, Ms. Wadlinger has played a vital role in establishing the culture at Forma and in evolving the organization from a company focused on research to now late …See details»
Forma Therapeutics to be acquired by Novo Nordisk in a
Sep 1, 2022 Forma Therapeutics Holdings Inc. announced Thursday and agreement to be acquired by Denmark-based Novo Nordisk in a deal with an equity value of $1.1 billion. Forma …See details»
FORMA Therapeutics Company Profile - Office Locations ... - Craft
FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. It has two core product candidates for …See details»
Forma Therapeutics Reviews 2020 Highlights and …
Jan 11, 2021 Investor Contact: Mario Corso, +1 781-366-5726 Forma Therapeutics [email protected] Release Summary Forma Therapeutics provides a review of 2020 company highlights and an outline of ...See details»
FORMA Therapeutics Announces Frank D. Lee as Chief Executive
Mar 21, 2019 During Steve’s time at FORMA, he championed the company’s evolution from a chemistry platform focused organization, toward a premiere research partner delivering high …See details»
FORMA Therapeutics - Overview, News & Similar companies
Jul 31, 2022 View FORMA Therapeutics (www.formatherapeutics.com) location in Massachusetts, United States , revenue, industry and description. ... Senior Vice President & …See details»
Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal
Sep 1, 2022 Danish drugmaker Novo Nordisk has agreed to buy Forma Therapeutics in a deal valued at $1.1 billion to expand its blood disorders portfolio, the companies said on Thursday.See details»
Novo Nordisk plows $1.1B for Forma Therapeutics with eye on SCD
Sep 1, 2022 Novo Nordisk is handing over $1.1 billion in cash to buy Forma Therapeutics in hopes that the clinical-stage biotech’s assets will help build a leading portfolio in sickle cell …See details»
Novo Nordisk to acquire Forma Therapeutics and expand
Sep 1, 2022 Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit …See details»
Pipeline - Forma Therapeutics
Leveraging our strong heritage of research and development, we’ve built our clinical development pipeline by selecting the most promising drug targets and chemical assets that align with our …See details»
Forma Therapeutics Reports Fourth Quarter and Year-End 2021 …
Mar 1, 2022 The presentation webcast will be available in the “News & Investors” section of Forma’s website at www.FormaTherapeutics.com. Virtual Research and Development (R&D) …See details»
Novo Nordisk | driving change to defeat serious chronic diseases
2 days ago Novo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the …See details»
Forma Therapeutics Reports Second Quarter 2022 ... - Business Wire
Aug 5, 2022 Statement of Operations Items: For the Three Months Ended June 30, For the Six Months Ended June 30, 2022 2021 2022 2021 Collaboration revenue $ — $ — $ —See details»